Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328
Clinical trial NCT00000923 · COMPLETED
Trial details
- NCT number
- NCT00000923
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.